Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients

Garcilazo-Reyes Ytel; Alentorn Agusti; Duran-Pena Alberto; Khe Hoang-Xuan; Houillier Caroline

首页> 外文期刊>Current treatment options in neurology >Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients

【24h】

Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients

机译：免疫活性患者中枢神经系统淋巴瘤治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose of review This review focuses on the findings of recent randomized prospective trials evaluating new therapeutic options for primary central nervous system lymphoma (PCNSL) in first-line treatment and on the most promising novel agents.

机译：审查目的本综述侧重于最近的随机性前瞻性试验调查结果，评估一线治疗中原发性中枢神经系统淋巴瘤（PCNSL）的新治疗选择，以及最有前途的新型药剂。

著录项

来源
《Current treatment options in neurology》 |2019年第8期|共10页
作者
Garcilazo-Reyes Ytel; Alentorn Agusti; Duran-Pena Alberto; Khe Hoang-Xuan; Houillier Caroline;
展开▼
作者单位

Grp Hosp Pitie Salpetriere AP HP Dept Neurol 2 Paris France;

Grp Hosp Pitie Salpetriere AP HP Dept Neurol 2 Paris France;

Grp Hosp Pitie Salpetriere AP HP Dept Neurol 2 Paris France;

Grp Hosp Pitie Salpetriere AP HP Dept Neurol 2 Paris France;

Grp Hosp Pitie Salpetriere AP HP Dept Neurol 2 Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Primary central nervous system lymphoma chemotherapy; Radiation therapy; Methotrexate; Autologous stem cell transplantation; Immunotherapy; Rituximab; Ibrutinib; Imids;

机译：中枢神经系统淋巴瘤化疗;放射治疗;甲氨蝶呤;自体干细胞移植;免疫疗法;rituximab;Ibrutinib;imids;

相似文献

外文文献
中文文献
专利

1. Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients [J] . Garcilazo-Reyes Ytel, Alentorn Agusti, Duran-Pena Alberto, Current treatment options in neurology . 2019,第8期

机译：免疫活性患者中枢神经系统淋巴瘤治疗
2. Primary central nervous system lymphoma in immunocompetent adults: poor results mainly associated with high treatment related toxicities. [J] . Depil S, Coiteux V, Guillerm G, Leukemia and lymphoma . 2002,第9期

机译：具有免疫功能的成年人的原发性中枢神经系统淋巴瘤：较差的结果主要与治疗相关的高毒性有关。
3. Epstein-Barr Virus-Positive Primary Central Nervous System Lymphoma in a 40-Year-Old Immunocompetent Patient [J] . Sabastian Hajtovic, Cynthia Liu, Catherine M. Diefenbach, Cureus. . 2021,第1期

机译：在40岁的免疫活性患者中，Epstein-BARR病毒阳性中枢神经系统淋巴瘤
4. Mutational profile of Diffuse Large B-cell Lymphoma with central nervous system relapse: analysis of CBioPortal for Cancer Genomics database [C] . Elena Voropaeva, Olga Beresina, Tatyana Pospelova, Conference on Cognitive Sciences, Genomics and Bioinformatics . 2020

机译：弥漫性大B细胞淋巴瘤与中枢神经系统复发的突变特征：用于癌症基因组学数据库的CBioPortal分析
5. Utility of apparent diffusion coefficients in the evaluation of primary central nervous system lymphoma. [D] . Gilbert, John Webster. 2012

机译：表观扩散系数在原发性中枢神经系统淋巴瘤评估中的应用。
6. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis [O] . Yaru Zou, Jianjing Tong, Haiyan Leng, 2017

机译：18F-FDG PET和PET / CT在具有免疫功能的原发性中枢神经系统淋巴瘤患者中的诊断价值：系统评价和荟萃分析
7. Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients [O] . Ytel Garcilazo-Reyes, Agusti Alentorn, Alberto Duran-Pena, 2019

机译：免疫活性患者中枢神经系统淋巴瘤的治疗

Treatment of Primary Central Nervous System Lymphoma in Immunocompetent Patients

摘要

著录项

相似文献

相关主题

期刊订阅